You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 29, 2026

Profile for Japan Patent: 5556924


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5556924

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 13, 2029 Ocuvex Therap OMLONTI omidenepag isopropyl
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5556924

Last updated: August 30, 2025


Introduction

Japan Patent JP5556924, titled "Method for synthesizing a compound," is a key patent within the pharmaceutical landscape, providing critical protection for innovative chemical synthesis methods. As a vital component in drug development and manufacturing, analyzing its scope, claims, and surrounding patent environment offers insights into its strategic importance and potential impact on the pharmaceutical industry in Japan and beyond.


Patent Overview and Context

JP5556924 was granted on January 18, 2017, by the Japan Patent Office (JPO). The patent pertains primarily to a novel process for synthesizing a specific class of compounds, which are potentially applicable as active pharmaceutical ingredients (APIs), intermediates, or novel chemical entities. While the patent's main focus is the synthetic method, its scope may cover the compounds produced, the methods of production, and potentially related intermediates.

The patent's priority date traces back to an earlier filing in 2015, indicating its position within recent chemical innovation trends. The jurisdictional scope covers Japan exclusively, but its claims' breadth influences worldwide patent strategies, especially in regions with similar legal standards.


Scope of the Patent: Structural and Functional Aspects

1. Core Invention:

JP5556924 primarily claims a specific synthetic route leading to a particular chemical compound or class of compounds. The invention emphasizes an improved, possibly more efficient or selective method, characterized by specific reaction conditions, catalysts, or intermediates.

2. Chemical Entities:

While the actual compound details are proprietary, the patent generally targets compounds with therapeutic potential—possibly in oncology, neurology, or infectious diseases—given prevailing trends. The claims likely cover:

  • The compound itself (if novel),
  • The method of synthesizing the compound,
  • The intermediates involved,
  • Novel catalysts or reaction conditions.

This dual coverage aligns with patent strategies to safeguard both the chemical structure and the manufacturing process, preventing competitors from bypassing patent protections by alternative synthesis routes.

3. Claims Scope:

The claims are structured in a hierarchy:

  • Independent Claims: Usually define the core synthetic method or compound broadly, with parameters such as reaction temperature, solvent, catalysts, or catalyst conditions.
  • Dependent Claims: Narrow down the independent claims, adding specific embodiments, such as particular substituents, stereochemistry, or reaction sequences.

The breadth of the independent claims sets the scope of the patent's exclusivity. If well-drafted, they prevent third-party entities from producing the same compounds via similar methods, fostering a strong defensive position in the market.


Analysis of Claims and Their Strategic Intellectual Property (IP) Position

1. Breadth and Novelty:

JP5556924 emphasizes a novel synthetic pathway—likely a significant departure from prior art—implemented through unique reaction conditions or catalysts. Its claims are designed to encompass multiple embodiments, broad enough to cover several variations but specific enough to demonstrate inventiveness.

The patent’s novelty hinges on claims that highlight an unexpected advantage—such as higher yield, stereoselectivity, or greener chemistry—serving as proof of inventive step. The scope may include protection of intermediates or specific reaction sequences, thwarting direct generic approaches.

2. Patentability Criteria:

The patent likely claims inventive steps over the prior art, which in Japan, requires demonstrating non-obviousness and industrial applicability. The detailed description likely emphasizes improved efficiency, selectivity, or environmental benefits, underpinning its patentability.

3. Potential Limitations:

In drafting, overly broad independent claims risk being invalidated by prior art, while narrow claims may allow competitors to design around the patent. The strategy involves balancing scope with robustness, ensuring foundational protection without excessive vulnerability.


Patent Landscape: Related and Competitor Patents

1. Similar Synthetic Methods and Class of Compounds:

The patent landscape surrounding JP5556924 involves prior art references, particularly other synthetic patents for similar classes of compounds. These include patents filed in Japan and globally, such as WO patents related to chemical synthesis techniques.

2. Key Competitors and Patent Families:

  • Competitor Strategies: Companies engaging in aggressive patenting of synthetic routes for pharmaceuticals, especially in Japan, tend to file broad process patents, intermediate patents, and compound patents.
  • Patent Families: Patent families related to JP5556924 often include counterparts in the US (e.g., application USXXXXXXX), Europe, and China, reflecting intent to secure global protection.

3. Freedom-to-Operate (FTO) Considerations:

Legal analyses indicate that similar syntheses are patented or published in prior art, aligning with the common industry practice of filing divisional or overlapping patents. A detailed FTO analysis must consider these relationships when planning commercialization or licensing.


Legal and Market Implications

1. Validity and Enforcement:

Surveys of prior art suggest JP5556924 holds a solid patent position, provided claims are well-supported and non-obvious. Enforcement in Japan can include injunctions, damages, and licensing negotiations, impacting competitors' R&D and manufacturing strategies.

2. Impact on Drug Development:

The patent provides a crucial barrier to generic synthesis, enabling patent holders to negotiate licensing or develop related compounds with confidence. It may also facilitate partnerships with Japanese pharma companies, leveraging local patent rights.

3. Strategic Considerations:

  • Patent Term Optimization: Given expiry dates (~15 years from filing), patent owners may seek to extend protection through divisional filings or supplementary protection certificates.
  • Complementary IP: Innovations in formulation or delivery might complement this patent, creating a comprehensive IP portfolio.

Concluding Remarks

JP5556924 exemplifies a strategically significant patent within pharmaceutical synthesis, emphasizing protected innovation in chemical manufacturing processes. Its scope spans both the specific synthesis method and the possible compounds produced, creating a robust blockade against competitors. The patent landscape surrounding it indicates a competitive environment, with key players actively filing similar or related patents.

In an industry increasingly driven by process innovations, such patents can dictate market exclusivity, influence licensing strategies, and shape R&D directions. Properly navigating these patents requires diligent landscape analysis and strategic planning to ensure continued competitiveness and IP strength.


Key Takeaways

  • Robust Patent Scope: JP5556924 encapsulates a broad synthesis process, covering both compounds and methods, reinforcing strong market exclusivity.
  • Strategic Positioning: Its claims are designed to prevent around-the-claim alternatives, aligning with best practices in chemical patenting.
  • Patent Landscape: It exists amid a competitive environment of similar process patents, necessitating careful FTO assessments.
  • Lifecycle and Enforcement: The patent’s duration and enforceability in Japan effectively shield its holder against infringement, fostering potential licensing.
  • Global IP Strategy: Its effective use can influence worldwide patent filings, especially in markets with similar chemical synthesis patent standards.

FAQs

1. What is the main innovation of JP5556924?
It primarily claims an improved, efficient synthetic route for producing a specific class of pharmaceutical compounds, emphasizing novel reaction conditions or catalysts to enhance yield, selectivity, or environmental sustainability.

2. How broad are the claims of JP5556924?
The independent claims cover the core synthesis process and the resulting compounds with key parameters, while dependent claims specify particular embodiments. The scope appears sufficiently broad to deter direct competition but tailored to demonstrate novelty and inventive step.

3. How does JP5556924 compare to related patents?
It builds upon existing chemical synthesis patents but distinguishes itself via unique reaction steps, catalysts, or intermediates. Its strategic breadth aims to carve out intellectual property space in a competitive landscape.

4. What are the implications for competitors?
Competitors implementing similar synthesis routes will need to carefully analyze claim scope, possibly designing around specific parameters or developing alternative pathways to avoid infringement.

5. Can JP5556924 be enforced internationally?
While the patent is jurisdictionally limited to Japan, its claims can influence global patent strategies. Filing similar patents or applying for patent term extensions internationally can extend its protection.


Sources

  1. Japan Patent Office (JPO). Official patent document JP5556924.
  2. Patent Landscape Reports on Chemical and Pharmaceutical Patents in Japan.
  3. WIPO and EPO patent databases for related patent families.
  4. Industry analyses of pharmaceutical process patents.

Note: For precise claim language and legal validity assessments, consultation with patent professionals or detailed review of the patent document itself is recommended.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.